Vietnam's medical device manufacturing sector is growing as MOH increases healthcare spending and the country seeks to reduce dependence on imported medical equipment. Local manufacturers like Vietmedical and Bach Khoa JSC produce basic devices, while FDI companies establish assembly facilities. MOIT's industrial development strategy targets medical device manufacturing as a priority sector, and AI-powered quality control and design optimization are becoming important as Vietnam moves toward producing more sophisticated medical devices domestically.
Vietnam's medical device manufacturing base is concentrated in low-complexity products like consumables and basic surgical instruments, limiting immediate AI applications for advanced device design. Regulatory approval through DAV (Drug Administration of Vietnam) under Decree 98/2021 is lengthy, and AI-integrated devices face additional scrutiny. The talent pool for biomedical engineering with AI skills is small, with only a few universities offering relevant programs. Competing with established manufacturers in China, Japan, and Germany for global market share requires significant quality and productivity improvements.
MOH and DAV regulate medical devices under Decree 98/2021, classifying devices from Class A (low risk) to Class D (high risk). AI-embedded medical devices face classification based on the AI component's clinical impact. Vietnam is harmonizing with ASEAN Medical Device Directive (AMDD) standards. GMP requirements for medical device manufacturing follow ISO 13485, and AI quality control systems must demonstrate compliance with both Vietnamese and international standards.
We understand the unique regulatory, procurement, and cultural context of operating in Vietnam
Vietnam's first comprehensive data protection law effective July 2024. Requires consent for personal data processing, notification of breaches, and data localization for sensitive categories. AI systems collecting personal data must comply with Ministry of Public Security regulations.
Requires foreign tech companies to store user data in Vietnam and establish local presence. Applies to AI platforms serving Vietnamese users. Mandates cooperation with government requests for data access.
Cybersecurity Law requires critical data (personal data, data affecting national security) to be stored in Vietnam. Banking data must remain in-country per State Bank of Vietnam (SBV) regulations. Foreign cloud providers must have Vietnam data centers or use local partners. Decree 13/2023 reinforces data localization requirements.
State-owned enterprises (SOEs) dominate economy with formal procurement requiring local partnership. Decision cycles 6-12 months with Communist Party approval for large projects. Private sector (Vingroup, FPT, Viettel) faster with 3-6 month cycles. Personal relationships and government connections critical. Budget approvals centralized at Ministry level for SOEs. Pilot budgets (500M-2B VND) approved at director level.
Government supports digital transformation through Project 06 (digital identity) and national digital transformation program. Ministry of Labour provides vocational training subsidies. Limited direct AI subsidies but growing under National Strategy on AI Development to 2030. State capital supports SOE technology adoption. Tax incentives for high-tech enterprises.
Vietnamese language training delivery essential - English proficiency lower than Singapore/Philippines. Communist Party influence requires government relationship management. Confucian values emphasize hierarchy and collective harmony. 'Saving face' culture requires diplomatic feedback delivery. Relationship building through shared meals and social events. North-South cultural differences (Hanoi vs Ho Chi Minh City) require localization.
Explore articles and research about AI implementation in this sector and region
Article
A guide to the best AI courses for Vietnamese companies in 2026. Corporate workshops in Ho Chi Minh City and Hanoi, government-supported programmes, and online options.
Article
Vietnam's Law on Artificial Intelligence, effective March 2026, is the first standalone binding AI law in Southeast Asia. It introduces risk-based classification, registration requirements, and penalties up to VND 2 billion for non-compliance.
Article
Navigate the complex landscape of AI regulations across Asia Pacific. From Singapore's AI Verify to Indonesia's PDP Law, understand compliance requirements across 6 key markets.
Article
Track 2026 AI regulatory changes across Singapore, Malaysia, Indonesia, and Hong Kong including enforcement trends, new guidance, and upcoming legislation.
Our team has trained executives at globally-recognized brands
YOUR PATH FORWARD
Every AI transformation is different, but the journey follows a proven sequence. Start where you are. Scale when you're ready.
ASSESS · 2-3 days
Understand exactly where you stand and where the biggest opportunities are. We map your AI maturity across strategy, data, technology, and culture, then hand you a prioritized action plan.
Get your AI Maturity ScorecardChoose your path
TRAIN · 1 day minimum
Upskill your leadership and teams so AI adoption sticks. Hands-on programs tailored to your industry, with measurable proficiency gains.
Explore training programsPROVE · 30 days
Deploy a working AI solution on a real business problem and measure actual results. Low risk, high signal. The fastest way to build internal conviction.
Launch a pilotSCALE · 1-6 months
Roll out what works across the organization with governance, change management, and measurable ROI. We embed with your team so capability transfers, not just deliverables.
Design your rolloutITERATE & ACCELERATE · Ongoing
AI moves fast. Regular reassessment ensures you stay ahead, not behind. We help you iterate, optimize, and capture new opportunities as the technology landscape shifts.
Plan your next phaseDecree 98/2021 classifies medical devices by risk level, and AI components are assessed based on their clinical decision-making role. Devices with AI providing diagnostic or therapeutic recommendations face higher classification requirements. DAV is developing specific guidance for software as a medical device (SaMD), and manufacturers should engage early with regulatory authorities as Vietnam's approach to AI medical device approval evolves.
Vietnam is building local medical device manufacturing capacity to reduce import dependence, with MOIT incentives for investment in medical technology. AI-driven quality control, supply chain optimization, and manufacturing process automation can help Vietnamese manufacturers meet ISO 13485 and GMP standards required for both domestic sales and exports to ASEAN markets under mutual recognition arrangements.
Let's discuss how we can help you achieve your AI transformation goals.
